Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06976515Active Not RecruitingPrimary

Study for Remote Investigation of Evaporative Dry Eye Disease

Showing all 1 trials

Research Network

Active Sponsors

  • That Man May See, Inc.1
  • University of California, San Francisco1

Top Investigators

Activity Timeline